Pain can soon be genetically eradicated.
Chronic pain, which is classified as a pain that lasts for 3 months or more, affects between 19 to 50 percent of the world population. Despite its prevalence, it remains a difficult diagnosis to treat well. In a new study, researchers say there may soon be a new treatment on the market to treat this pain thanks to the famous gene-editing toolkit — CRISPR-Cas9. This technology could allow patients to side-step the need for opioids altogether.
Source
https://www.inverse.com/innovation/crispr-chronic-pain-opioid-study